Stevanato Group Net Receivables Over Time
| STVN Stock | USD 20.03 0.03 0.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Stevanato Group Performance and Stevanato Group Correlation. Stevanato |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stevanato Group. If investors know Stevanato will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stevanato Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Dividend Share 0.053 | Earnings Share 0.45 | Revenue Per Share 4.063 | Quarterly Revenue Growth 0.024 |
The market value of Stevanato Group SpA is measured differently than its book value, which is the value of Stevanato that is recorded on the company's balance sheet. Investors also form their own opinion of Stevanato Group's value that differs from its market value or its book value, called intrinsic value, which is Stevanato Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stevanato Group's market value can be influenced by many factors that don't directly affect Stevanato Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stevanato Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stevanato Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stevanato Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Receivables Analysis
Compare Stevanato Group SpA and related stocks such as Haemonetics, Merit Medical Systems, and AngioDynamics Net Receivables Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE | 33.4 M | 135.5 M | 170.1 M | 165 M | 145.8 M | 157.1 M | 152.7 M | 151.2 M | 185 M | 165.2 M | 127.6 M | 159.4 M | 179.1 M | 206.6 M | 120.7 M |
| MMSI | 300 K | 45.3 M | 57.3 M | 64.1 M | 80.6 M | 78.2 M | 86.6 M | 116.2 M | 150 M | 168.5 M | 158 M | 172.8 M | 178.4 M | 189.3 M | 198.7 M |
| ANGO | 4.5 M | 51.1 M | 48.1 M | 62.2 M | 58.4 M | 52.9 M | 44.5 M | 39.4 M | 43.6 M | 31.3 M | 35.4 M | 52.3 M | 52.8 M | 43.6 M | 38.7 M |
| ATR | 74.5 M | 389 M | 396.8 M | 438.2 M | 407 M | 377 M | 433.1 M | 510.4 M | 569.6 M | 558.4 M | 566.6 M | 671.4 M | 693.7 M | 695.9 M | 369.9 M |
| NVST | 463.1 M | 463.1 M | 463.1 M | 463.1 M | 463.1 M | 463.1 M | 463.1 M | 463.1 M | 459.8 M | 443.6 M | 301.7 M | 331.9 M | 393.5 M | 407.5 M | 320.1 M |
| ICUI | 800 K | 47.7 M | 49.1 M | 45.3 M | 39.1 M | 57.8 M | 56.2 M | 219.6 M | 196.4 M | 202.2 M | 124.1 M | 105.9 M | 221.7 M | 182.1 M | 191.3 M |
| COO | 119.5 M | 234.3 M | 229.5 M | 276.3 M | 282.9 M | 291.4 M | 316.6 M | 374.7 M | 435.3 M | 435.4 M | 515.3 M | 557.8 M | 609.7 M | 701.2 M | 736.2 M |
| TFX | 33.4 M | 286.2 M | 298 M | 295.3 M | 273.7 M | 262.4 M | 272 M | 345.9 M | 366.3 M | 418.7 M | 395.1 M | 383.6 M | 408.8 M | 443.5 M | 306.2 M |
| WST | 23.3 M | 147.2 M | 175 M | 185.7 M | 179 M | 181.4 M | 200.5 M | 253.2 M | 288.2 M | 319.3 M | 385.3 M | 489 M | 507.4 M | 512 M | 537.6 M |
| ALC | 547.5 M | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.5 B | 1.8 B | 1.7 B | 1.8 B | 1.6 B | 1.7 B | 1.9 B | 2.1 B | 1.6 B |
| RMD | 1.5 M | 285.4 M | 318.3 M | 359.6 M | 362.6 M | 382.1 M | 450.5 M | 483.7 M | 528.5 M | 474.6 M | 614.3 M | 576 M | 704.9 M | 837.3 M | 879.1 M |
| XRAY | 1.5 M | 427.7 M | 442.4 M | 472.8 M | 426.6 M | 399.9 M | 636 M | 746.2 M | 701.9 M | 782 M | 709 M | 803 M | 632 M | 756 M | 793.8 M |
| ATRC | 3.5 M | 9.5 M | 9.9 M | 13.7 M | 17.6 M | 19.4 M | 21.1 M | 23.1 M | 25.2 M | 28 M | 23.1 M | 33 M | 42.7 M | 52.5 M | 55.1 M |
| AKYA | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 6.5 M | 9.4 M | 9.7 M | 17 M | 12.3 M |
Stevanato Group SpA and related stocks such as Haemonetics, Merit Medical Systems, and AngioDynamics Net Receivables description
My Equities
My Current Equities and Potential Positions
| Stevanato Group SpA | STVN |
| Classification | Shipping Containers |
| Location | Italy |
| Exchange | New York Stock Exchange |
USD 20.03
Check out Stevanato Group Performance and Stevanato Group Correlation. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Stevanato Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.